Health Care & Life Sciences » Pharmaceuticals | Imprimis Pharmaceuticals Inc.

Imprimis Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
10.00
1,660.20
9,716.00
19,942.00
26,774.00
Cost of Goods Sold (COGS) incl. D&A
5.70
1,092.80
5,206.00
9,831.00
13,505.00
Gross Income
4.30
567.40
4,510.00
10,111.00
13,269.00
SG&A Expense
7,691.20
10,714.20
19,332.00
25,690.00
25,432.00
EBIT
7,686.90
10,146.80
14,822.00
15,579.00
12,163.00
Unusual Expense
-
-
-
2,611.00
884.00
Non Operating Income/Expense
-
-
31.00
1,766.00
5,371.00
Interest Expense
-
3.80
1,121.00
2,784.00
3,073.00
Pretax Income
7,643.10
10,118.10
15,899.00
19,198.00
12,920.00
Income Tax
-
-
-
111.00
935.00
Consolidated Net Income
7,643.10
10,118.10
15,899.00
19,087.00
11,985.00
Net Income
7,643.10
10,118.10
15,899.00
19,087.00
11,985.00
Net Income After Extraordinaries
7,643.10
10,118.10
15,899.00
19,087.00
11,985.00
Net Income Available to Common
7,643.10
10,118.10
15,899.00
19,087.00
11,985.00
EPS (Basic)
0.88
1.11
1.66
1.50
0.60
Basic Shares Outstanding
8,656.80
9,133.00
9,576.10
12,743.20
20,027.70
EPS (Diluted)
0.88
1.11
1.66
1.50
0.60
Diluted Shares Outstanding
8,656.80
9,133.00
9,576.10
12,743.20
20,027.70
EBITDA
7,681.20
10,061.40
14,212.00
14,173.00
10,398.00
Non-Operating Interest Income
43.80
32.40
13.00
10.00
47.00
Equity in Affiliates (Pretax)
-
-
-
-
2,218.00

About Imprimis Pharmaceuticals

View Profile
Address
12264 El Camino Real
San Diego California 92130
United States
Employees -
Website http://www.imprimispharma.com
Updated 09/14/2018
Imprimis Pharmaceuticals, Inc. engages in the development, production, and dispensing of innovative proprietary compounded pharmaceuticals. The company was founded by Mark L. Baum and Robert J.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.